BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Kumar J, Reccia I, Virdis F, Podda M, Sharma AK, Halawa A. Belatacept in renal transplantation in comparison to tacrolimus and molecular understanding of resistance pattern: Meta-analysis and systematic review. World J Transplant 2021; 11(3): 70-86 [PMID: 33816147 DOI: 10.5500/wjt.v11.i3.70]
URL: https://www.wjgnet.com/2220-3230/full/v11/i3/70.htm
Number Citing Articles
1
Adnan Sharif. Interventions Against Posttransplantation Diabetes: A Scientific Rationale for Treatment Hierarchy Based on Literature ReviewTransplantation 2022; 106(12): 2301 doi: 10.1097/TP.0000000000004198
2
Gil-Ran Kim, Kyung-Ho Nam, Je-Min Choi. Belatacept and regulatory T cells in transplantation: synergistic strategies for immune tolerance and graft survivalClinical Transplantation and Research 2024; 38(4): 326 doi: 10.4285/ctr.24.0057
3
Florence Herr, Christophe Desterke, Karen Bargiel, Amelia Vernochet, Bernard Vanhove, Radu Vadanici, Fan Ye, Manon Dekeyser, Antoine Durrbach. The proliferation of belatacept-resistant T cells requires early IFNα pathway activationAmerican Journal of Transplantation 2022; 22(2): 489 doi: 10.1111/ajt.16811
4
Gonca E. Karahan, Frans H. J. Claas, Sebastiaan Heidt. Heterologous Immunity of Virus-Specific T Cells Leading to Alloreactivity: Possible Implications for Solid Organ TransplantationViruses 2021; 13(12): 2359 doi: 10.3390/v13122359
5
Steven Gabardi. Immunosuppression in the Age of Precision MedicineSeminars in Nephrology 2022; 42(1): 86 doi: 10.1016/j.semnephrol.2022.01.001
6
Stalin Canizares, Adriana Montalvan, Devin Eckhoff, Kalathil K. Sureshkumar, Bhavna Chopra. Long Term Outcomes of Transplant Recipients Comparing Belatacept vs. Tacrolimus: A UNOS Database AnalysisClinical Transplantation 2025; 39(2) doi: 10.1111/ctr.70075
7
Maha Zafar, Reshly Mary Rajan, Rija T. Ahmed, Aswanth Reddy. Disseminated Histoplasmosis with Secondary Hemophagocytic Lymphohistiocytosis in a Renal Transplant Recipient on Belatacept-based ImmunosuppressionJournal of Brown Hospital Medicine 2024; 3(3) doi: 10.56305/001c.118963
8
Arun Prabhahar, Akshey Batta, Juniali Hatwal, Vivek Kumar, Raja Ramachandran, Akash Batta. Endothelial dysfunction in the kidney transplant population: Current evidence and management strategiesWorld Journal of Transplantation 2025; 15(1): 97458 doi: 10.5500/wjt.v15.i1.97458
9
Alan D. Kaye, Shivam S. Shah, Coplen D. Johnson, Adalyn S. De Witt, Austin S. Thomassen, Charles P. Daniel, Shahab Ahmadzadeh, Sridhar Tirumala, Kristin Nicole Bembenick, Adam M. Kaye, Sahar Shekoohi. Tacrolimus- and Mycophenolate-Mediated Toxicity: Clinical Considerations and Options in Management of Post-Transplant PatientsCurrent Issues in Molecular Biology 2024; 47(1): 2 doi: 10.3390/cimb47010002
10
Syvart Dennen, Oliver Díaz Espinosa, Kelly Birch, Jennifer Cai, Jennifer C. Sung, Paula G. P. Machado, Jason Shafrin. Quantifying spillover benefits in value assessment: a case study of increased graft survival on the US kidney transplant waitlistJournal of Medical Economics 2021; 24(1): 918 doi: 10.1080/13696998.2021.1957287
11
Peenida Skulratanasak, Nuttasith Larpparisuth. Lipid management to mitigate poorer postkidney transplant outcomesCurrent Opinion in Nephrology & Hypertension 2022;  doi: 10.1097/MNH.0000000000000841
12
Adnan Sharif. Metabolic Syndrome2024; : 439 doi: 10.1016/B978-0-323-85732-1.00045-1
13
Rita Eid, Anne Scemla, Magali Giral, Nadia Arzouk, Dominique Bertrand, Marie-Noëlle Peraldi, Laurent Mesnard, Helene Longuet, Mehdi Maanaoui, Geoffroy Desbuissons, Edouard Lefevre, Renaud Snanoudj. Use of a Belatacept-based Immunosuppression for Kidney Transplantation From Donors After Circulatory Death: A Paired Kidney AnalysisTransplantation Direct 2024; 10(5): e1615 doi: 10.1097/TXD.0000000000001615
14
Katie L. Alexander, Mandy L. Ford. The Entangled World of Memory T Cells and Implications in TransplantationTransplantation 2024; 108(1): 137 doi: 10.1097/TP.0000000000004647